Synairgen: shares soar of positive Covid-19 test results
The share price of Synairgen (LON: SNG), the AIM quoted respiratory drug discovery company, soared over 350% as it announced positive results from its clinical trial of SNG001, its wholly-owned inhaled formulation of interferon beta, in hospitalised Covid-19 patients.
The trial results showed that SNG001 greatly reduced the number of hospitalised Covid-19 patients who progressed from ‘requiring oxygen’ to ‘requiring ventilation’. It also showed that patients who received…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on Gamma Communications
26/03/2025 · Company Insights
This fast-growing provider of unified communications is a fantastic company, generating attractive operating margins and heaps…
13/01/2023 · Company Insights
Updates covered here include several AIM and small cap companies offering high dividend payouts. While some…
More on MJ Hudson Group PLC
12/12/2022 · Company Insights
Updates from AIM covered here includes news of the suspension of trading in the shares of a…
20/07/2020 · Company Insights
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
More on Pittards
30/09/2020 · Company Insights
Boohoo Group announced another set of fantastic results and, with a huge pile of cash at…
20/07/2020 · Company Insights
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
More on Synairgen
21/10/2021 · Company Insights
A new strategy appears to be delivering for an unusual business covered here. Elsewhere, a small…
20/07/2020 · Company Insights
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
More on Venture Life
04/02/2025 · Company Insights
News covered in the update here includes our assessment of impressive results from one of our…
01/02/2022 · Company Insights
One of AIM’s largest companies has issued another positive trading update sending the shares sharply higher…
More Company Insights
New plans from online wine retailers are well received
Cash continues to flow into this big dividend payer
Cash and asset-rich Bonkers Bargain better-placed than rivals
More on Gamma Communications
More on MJ Hudson Group PLC
More on Pittards
More on Synairgen
More on Venture Life
More Company Insights